Not applicableStudy completedNCT01465360
What this trial is testing
Performance of AclarusDx™, a Blood-Based Transcriptomic Test for AD, in US Patients Newly Referred to a Memory Center
Who this might be right for
Alzheimer's DiseaseMild Cognitive ImpairmentVascular Dementia+4 more
Exonhit 160